Posts Tagged 'testosterone'

Androgel Maker Ordered to Pay Up With $150 Million Verdict

Androgel maker loses case for $150 million verdictOne would think that a verdict of this magnitude would send a very loud, very clear message to Androgel maker AbbVie. Unfortunately, the testosterone therapy maker may actually escape paying on this verdict, calling into question whether the company will still “hear” the jury.

The $150 million testosterone verdict was just issued in the case of an Oregon man whose lawsuit accused AbbVie of hiding the risk of ...

continue reading...

Endocrinology Groups Echo FDA Call for More Research on Testosterone Therapy Risks

endocrinologist group calls for testosterone therapy researchThe American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) recently issued a joint position statement on the cardiovascular risks of testosterone therapy. In the statement, the two endocrinology groups questioned the FDA’s recommended method for determining whether a patient requires testosterone therapy and call for more research on the health risks posed by Low-T products.

The FDA has indicated that testosterone therapy is approved ...

continue reading...

New Study Unable to Show Testosterone Does Not Increase CV Risk

controversial study claims no cardiovascular risk with testosterone therapyA new study published in the Mayo Clinic Proceedings purports to show that testosterone therapy does not increase the risk of deep vein thrombosis (DVT) or pulmonary embolism (PE), though the validity of these results may be questionable.

Testosterone therapy products are intended to regulate hormone levels in men with medically confirmed low testosterone. (The drugs are not approved for use in men experiencing the natural testosterone-lowering ...

continue reading...

AbbVie Profits Rise 4.3% as Testosterone Lawsuits Mount

abbvie profits on the risePharmaceutical giant AbbVie, Inc. has reported a 4.3 percent increase in its first-quarter profits, according to Nasdaq. The Chicago-based company cited heightened sales of anti-inflammatory medications, and detailed its plans to keep its top-selling drug Humira afloat.

Despite the rise in profits, AbbVie still faces financial trouble in the form of testosterone lawsuits. The company’s popular “low-T” product, AndroGel, is one of a handful or prescription testosterone treatments that have ...

continue reading...

Testosterone Therapy Linked to Decreased Cognition in Caucasian Men

testosterone therapy treatments linked to decreased cognitionScientists at the University of North Texas Health Science Center have released a study citing links between testosterone therapy and cognitive issues in Caucasian men. The study focused on the effect of testosterone-replacement therapy on men suffering from oxidative stress, a condition correlated with blood clots. According to the article, oxidative stress can in turn cause testosterone therapy to have additional side-effects.

The study indicates that in Caucasian males with ...

continue reading...

FDA Adds New Warning for Testosterone Therapy Products

The Food and Drug Administration (FDA) recently issued a new safety alert stating that men who use testosterone therapy products are at an increased risk for venous blood clots, a condition referred to as venous thromboembolism (VTE). The FDA is requiring all manufacturers of testosterone therapy products to include on labels a general warning about the heightened VTE risks.

Venous blood clots are as they sound — blood clots that occur in the veins. They ...

continue reading...
Page 1 of 3 123